Showing results (11-20 of 152) with videos related to
Sort By:
Pageof 16
Kidney International. Supplement|July 21, 1999
Ongoing clinical trials of lipid reduction therapy in patients with renal diseaseS Yukawa, M Mune, Y Yamada, et al.Kidney International. Supplement|July 21, 1999
Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patientsT Goto, H Saika, T Takahashi, et al.Kidney International. Supplement|July 21, 1999
Vitamin E treatment of experimental glomerular disease in ratsH Otani, M Mune, S Yukawa, et al.Kidney International. Supplement|July 21, 1999
Factors associated with calcification of the abdominal aorta in hemodialysis patientsK Kimura, Y Saika, H Otani, et al.Kidney International. Supplement|July 21, 1999
Evaluation of serum lipid abnormalities in chronic nephritisH Hirano, Y Yamada, H Otani, et al.Kidney International. Supplement|July 21, 1999
Phospholipase A2 activity in ox-LDL-stimulated mesangial cells and modulation by alpha-tocopherolM Ozaki, Y Yamada, K Matoba, et al.Biochemistry. Biokhimiia|February 20, 2004
Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humansG S Yukawa, M Mune, H Otani, et al.Kidney International. Supplement|July 21, 1999
Lysophosphatidylcholine up-regulates IL-1 beta-induced iNOS expression in rat mesangial cellsM Taniuchi, H Otani, N Kodama, et al.Nihon Jinzo Gakkai Shi|August 12, 1999
[Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol]Y Saika, N Kodama, K Kimura, et al.Nihon Jinzo Gakkai Shi|November 1, 1990
[Glomerular apolipoprotein B deposition in glomerular diseases]H Ohtani, K Matoba, Y Saika, et al.Pageof 16